Background Non-alcoholic fatty liver disease, or as recently proposed 'metabolic-associated
fatty liver disease'(MAFLD), is characterized by pathological accumulation of triglycerides …

The prevalence of non-alcoholic fatty liver disease (NAFLD) has been increasing rapidly
and at the forefront of worldwide concern. Characterized by excessive fat accumulation in …

Purpose To explore the association between γ-glutamyl transpeptidase to high-density
lipoprotein ratio (GGT/HDL), triglyceride glucose-body mass index (TYG-BMI), and metabolic …

Dyslipidemia is a critical factor in the development of atherosclerosis and consequent
cardiovascular disease. Numerous pieces of evidence demonstrate the association between …

In addition to being the main determinant of dyslipidemia, disturbances in triglyceride-rich
lipoproteins are thought to be the key factor of increased CVD risk in NAFLD. Treatments …

Triple-negative breast cancer (TNBC) is a highly metastatic and heterogeneous type of
breast cancer with poor outcomes. Precise, non-invasive methods for diagnosis, monitoring …

Background Non-alcoholic fatty liver disease (NAFLD) patients are at a substantial risk for
developing cardiovascular disease (CVD). High-density lipoprotein (HDL) is well known to …

Background Lipoprotein disturbances have been associated with increased cardiovascular
disease (CVD) risk in type 1 diabetes mellitus (T1DM). We assessed the advanced …

ApoB is the main protein of triglyceride-rich lipoproteins and is further divided into ApoB48 in
the intestine and ApoB100 in the liver. Very low-density lipoprotein (VLDL) is produced by …

Fatty liver disease is a serious complication of childhood obesity. Calorie-restricted regimen
(RCR) is one of the effective therapy for this condition. Aim of the study was to evaluate the …